Seres Therapeutics Files 8-K Announcing Entry into Material Agreement

Seres Therapeutics disclosed a significant new agreement via an 8-K filing, signaling potential strategic moves or financial changes. This update could influence investor perception and future valuation. Watch for further developments or official statements from Seres regarding the deal's details and impact.